The United States Peripheral Artery Disease (PAD) Interventional Landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook (2019-2022)

September 2022
The China Peripheral Artery Disease (PAD) report is the first-ever syndicated report that covers the market landscape, procedural and technology trends, and competitive intelligence. The report is based on exhaustive secondary research and in-depth primary research conducted with more than 100 performing physicians in Interventional Radiology, Interventional Cardiology, Vascular Surgery, and General Surgery departments from level 2 and level 3 hospitals in China.
    The report covers:

  • Peripheral interventional procedures: lower extremity and upper extremity procedures
  • Interventional devices: peripheral stents, peripheral angioplasty balloons, atherectomy devices, carotid artery stents, and embolic protection devices.
  • Procedure trends: by facility type, stages of the disease, artery location, performing departments, route of access used for the intervention, and patient discharge.
Mustang balloon – they track very well through tight stenosis or through occlusions. They expand in a predictable way. You can use them easily. That’s not true of all the brands. its reliable and re-usable.

Coyote – it just traps very nicely through even long segment chronic occlusions it will track very well.

Nanocross – this a nice, tapered option because these vessels do get smaller as you go down towards the foot so there is less risk of causing injury to the more distal arteries. That is a nice feature of that balloon.”

– Interventional Radiologist, USA​

  • ~30% of peripheral artery interventions are performed in mild-moderate cases
  • ~65% of lower extremity procedures, patients are discharged the same day
  • ~30% of peripheral artery interventions are performed below the knee (BTK)

Reimbursement of peripheral stenting and angioplasty does not have much difference; however, there is low uptake of carotid artery stenting due to stringent conditions for reimbursement.

Physicians’ brand perception and their rank of medical device companies based on 15 KPIs such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of the device, and cost-effectiveness among others effecting brand usage have been covered.

Future Trends for PAD treatment landscape show that Transcarotid Artery Revascularization TCAR has the potential to replace carotid endarterectomy. Development of early detection and optimal referral pathway are expected to increase procedure volumes for peripheral vascular interventions. The availability of new angioplasty techniques such as shockwave technology will have a positive impact on the procedure trends.

Competitor landscape covered in this report includes the recent approval of IN. PACT 018 a low-profile drug-coated balloon platform from Medtronic, the product is indicated for the treatment of peripheral arterial disease in superficial femoral and popliteal arteries; and the acquisition of Straub Medical AG, a developer of atherectomy and thrombectomy devices for PAD and venous diseases, by BD in 2020.

What’s in it for you?

  • This report will help peripheral artery devices (PAD) interventional devices companies understand the peripheral artery intervention landscape, procedural and technology trends, brand perception, and competitive intelligence in the USA.
  • The report is a great resource to plan your market strategy to capitalize on upcoming trends and potential disruptors in the PAD interventional devices
The deliverable includes a 100+ slide MS PowerPoint report and an MS Excel-based 5-Year market forecast model.
REPORT COST: 5,000 USD
Contact us below for further details regarding the exclusive data and insights in the report or for an exploratory analyst walkthrough of the report.

    Drop Us A Line

    We provide the best insights for your business